healthcare-industry-dynamics

The study involved 4 major activities in estimating the current market size for Global Pharmaceutical Excipients Market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. 

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

The study involved two major activities in estimating the current market size of the Human Microbiome Market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Recent Developments:

# In 2019, Seres collaborated with AstraZeneca to get a better understanding of the microbiome in augmenting the efficacy of cancer immunotherapy, including potential synergy with AstraZeneca compounds.

# In 2018, Enterome entered into a co-development and co-promotion agreement with Takeda for its investigational drug candidate EB8018. This drug is used in patients with Crohn's disease and has the potential to expand its use to other gastrointestinal (GI) disorders and liver diseases.

In 2016, 4D Pharma acquired the production assets of Instituto Biomar to expand its clinical and production capabilities of live biotherapeutics.

Key questions addressed by the report:

Who are the major market players in the human microbiome market?

What are the regional growth trends and the largest revenue-generating regions for the market?

What are the major drivers and challenges in the market?

What are the major product segments in the market?

What are the major technologies used in the human microbiome research spending market?

Find More Details | Get the Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=37621904

Factors Influencing Global Growth:-

Market growth is largely driven by the increasing focus on the development of human microbiome therapy. It has also become a validated target for drug development. The growing number of collaborations between market players is expected to offer a wide range of growth opportunities for market players during the forecast period.

Restraint:

# Lack of Expertise and Detailed Research

# Barriers in Proving the Causal Link Between Dysbiosis and Disease

Opportunity:

# Investigational New Drug Requirements for Fecal Microbiota

# Increasing Collaborations

Market Challenge:

# Government Regulations

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The human microbiome market is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5% during 2024–2027.

Feel FREE to Connect to Our Research Experts@

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=37621904

Geographical Growth Scenario:

Europe to account for the largest share of the human microbiome market in 2022

On the basis of region, the global human microbiome market is segmented into four major geographies— North America, Europe, the Asia Pacific, and the Rest of the World (RoW). Europe is expected to account for the largest share of the global human microbiome market in 2022. The large share of this regional segment is mainly due to the high research activity in this region.

Leading Market Players:

# Enterome Bioscience (France)

# E.I. du Pont de Nemours and Company (DuPont) (US)

# 4D Pharma (UK)

# Seres Therapeutics (US) and many more…

The study involved four major activities in estimating the current size of the Global Tracheostomy Products Market. Exhaustive secondary research was carried out to collect information on the market and its different sub-segments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and sub-segments.

Recent Developments in the Global Industry:

# In February 2019, Medtronic Plc entered into a partnership with Medical University of South Carolina (US) for the development of better and affordable healthcare solutions (including tracheostomy procedure for breathing assistance) for patients

# In October 2017, Medtronic Plc established the Chengdu Innovation Center at Singapore for cross-disciplinary clinical training and R&D.

Key Questions Addressed in this Report:

# Emerging countries are offering immense opportunities for the growth and adoption of market. Will this scenario continue in the coming years?

# Where will all the advancements in products offered by various companies take the industry in the mid-to-long term?

# What are the various research institutes where tracheostomy products find a high adoption rate?

# What are the new trends and advancements in the market?

# How is the shift in dynamics shaping the future of the market?

Find More Details | Get the Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=79626751

Factors Influencing Global Growth:-

The major factors driving the growth of the tracheostomy products market are the availability of clinical evidence for their safety & efficacy and increasing adoption of tracheostomy procedures among medical professionals owing to procedural benefits offered by tracheostomy products. Moreover, the rising demand for home care services is expected to play a significant role in fueling market growth.

Restraint:

# High Cost of Tracheostomy Procedures

# Increasing Pricing Pressure on Market Players

Opportunity:

# Emerging Markets

Market Challenge:

# Dearth of Skilled Surgeons

Monetary Growth Expectations, Globally:

According to the Research Study conducted by MarketsandMarkets™: The tracheostomy products market size is projected to reach USD 220 million by 2024 from USD 179 million in 2019, at a CAGR of 4.2%.

Feel FREE to Connect to Our Research Experts@

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=79626751

Geographical Growth Scenario:

North America is expected to account for the largest share of the healthcare claims management market in 2018, followed by Europe. The large share of North America can be attributed to the high and growing HCIT investments in the region and the presence of regulatory mandates favoring the implementation of healthcare claims management solutions. Also, several major global players are based in the US, owing to which the US has become a center for innovation in the healthcare claims management solutions market.

Leading Market Players:

# Medtronic plc (Ireland)

# Smiths Group plc (UK)

# TRACOE Medical GmbH (Germany)

# Teleflex Incorporated (US)

# Fisher & Paykel Healthcare Ltd. (New Zealand) and many more…

The analysis of market developments between 2015 and 2019 revealed that several growth strategies such as collaborations and market expansions were adopted by players to strengthen their product portfolio and maintain a competitive position in the tracheostomy products market.

The study involved four major activities in estimating the current size of the tracheostomy products market. Exhaustive secondary research was carried out to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and sub-segments.

Recent Developments:

# In February 2019, Medtronic Plc entered into a partnership with Medical University of South Carolina (US) for the development of better and affordable healthcare solutions (including tracheostomy procedure for breathing assistance) for patients

# In October 2017, Medtronic Plc established the Chengdu Innovation Center at Singapore for cross-disciplinary clinical training and R&D.

Key Questions Addressed by the Report:

# Emerging countries are offering immense opportunities for the growth and adoption of market. Will this scenario continue in the coming years?

# Where will all the advancements in products offered by various companies take the industry in the mid-to-long term?

# What are the various research institutes where tracheostomy products find a high adoption rate?

# What are the new trends and advancements in the market?

# How is the shift in dynamics shaping the future of the market?

Find More Details | Get the Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=79626751

Factors Influencing Global Growth:-

The major factors driving the growth of the tracheostomy products market are the availability of clinical evidence for their safety & efficacy and increasing adoption of tracheostomy procedures among medical professionals owing to procedural benefits offered by tracheostomy products. Moreover, the rising demand for home care services is expected to play a significant role in fueling market growth.

Restraints:

# High Cost of Tracheostomy Procedures

# Increasing Pricing Pressure on Market Players

Opportunities:

# Emerging Markets

Challenges:

# Dearth of Skilled Surgeons

Monetary Growth Expectations, Globally:

The tracheostomy products market size is projected to reach USD 220 million by 2024 from USD 179 million in 2019, at a CAGR of 4.2%.

Geographical Growth Scenario:

The market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2018.

Factors such as the presence of a highly developed healthcare system, an increasing number of emergency department visits, high adoption of innovative tracheostomy devices among medical professionals, and wide availability of advanced tracheostomy devices are driving the market for tracheostomy products in North America.

Feel FREE to Connect to Our Research Experts@

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=79626751

Leading Market Players:

# Medtronic plc (Ireland)

# Smiths Group plc (UK)

# TRACOE Medical GmbH (Germany)

# Teleflex Incorporated (US)

# Fisher & Paykel Healthcare Ltd. (New Zealand) and many more…

The analysis of market developments between 2015 and 2019 revealed that several growth strategies such as collaborations and market expansions were adopted by players to strengthen their product portfolio and maintain a competitive position in the tracheostomy products market.

The report segments the organ preservation market based on preservation solution, technique and organ type. The University of Wisconsin solution segment is expected to account for the largest share of the market, by preservation solution in 2016 and is expected to grow at highest CAGR.

This large share can be attributed to its prolific usage in the storage of kidney, liver, and pancreas, better transplantation outcomes, less histological damage, and improved physiological function of organs.

Target Audience for this Report:

# Preservation Solutions and Devices Providers
# Life Sciences Companies
# Medical Device Manufacturers
# Market Research and Consulting Firms
# Healthcare Service Providers
# Medical Research Institutes
# Regulatory Bodies
# Venture Capitalists

Find More Details | Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=261269915

Factors Influencing Global Growth:-

The growth of the overall market can be contributed to rising multi-organ failure cases in aging population, technological advancements, increasing government initiatives to promote organ donation and rising number of solid-organ transplant procedures. In the coming years, the market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global market.

Restraints:
# High Cost of Organ Transplantation

Opportunities:
# Normothermic Machine Perfusion: A New Paradigm for Organ Preservation

Challenges:
# Significant Gap Between Number of Organs Donated and Organs Required Annually
# Limited Medical Reimbursements for Organ Donation and Transplantation

Monetary Growth Expectations, Globally:

The market is expected to reach USD 241.2 Million by 2021 from USD 165.9 Million in 2016 at a CAGR of 7.8% during the forecast period.

Geographical Growth Scenario:

On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the organ preservation market. Its large share can be attributed to growing cases of kidney failure, rising organ transplants, favorable reimbursements scenario within some provinces in Canada, and novel technological advancements by U.S. players.

However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period due to the new regulatory framework in China, and increasing organ donations in Asia-Pacific and serve as a revenue pocket for companies offering organ preservation solutions and transport systems

Feel FREE to Connect to Our Research Experts@
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=261269915

Leading Market Players:

# Organ Recovery Systems (U.S.)
# Xvivo Perfusion AB (Sweden)
# Essential Pharmaceuticals LLC (U.S.)
# Dr. Franz Kohler Chemie GmbH (Germany)
# Waters Medical Systems LLC (U.S. and many more…

Client acquisitions, approvals & certifications, market expansions, and other (product launches and integrations, agreements, and contracts) are the major developments undertaken by the players to achieve growth in this market. Client acquisitions accounted for ~41% of the total developments undertaken by the players in this market.

Filtration is an important operation in the pharmaceutical industry, as it not only ensures that the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.

Target Audience for this Report:

# Academic and government research institutes

# Pharmaceutical and biotechnology companies

# Food & beverage industry

# Contract research organizations (CROs)

# Market research & consulting firms

# Filter manufacturers, vendors, and distributors

Find More Details | Get the Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=256410424

Factors Influencing Global Growth:-

Increase in R&D spending, growth in the biopharmaceutical industry, growing demand for biopharmaceutical molecules, rising incidence of diabetes & kidney failure, and increasing purity requirement in end-users, are the primary growth drivers for this market during the forecast period (2015–2020).

Restraints:

# Stringent Government Regulations for Validation of Filtration Processes

Opportunities:

# Rising Opportunities in Emerging Markets

# Creation and Use of Advanced Filters for Sterile Filtration

Challenges:

# Intense Competition Acts as an Entry Barrier for New Entrants

# Huge Capital Expenditure Required to Set Up New Production Facilities

Monetary Growth Expectations, Globally:

The global sterile filtration market is expected to reach USD 7.46 Billion by 2020 from USD 4.00 Billion in 2015, at a CAGR of 12.4% from 2015 to 2020.

Geographical Growth Scenario:

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The report maps each product, application, membrane pore size, and end-user segment in 6 geographic and regional segments. Geographic analysis reveals that North America accounted for the largest share of the global sterile filtration market in 2015.

Growth in this market can be attributed to the growth of biopharmaceutical industry and increase in R&D spending. Similarly Asia is estimated to be the fastest growing market of the global market in 2015. The wide applications of sterile filtration products in lab-scale DNA and protein separation, drug screening, cell culturing, and examination and virus removal are the major driving factor for sterile filtration market in this region.

Feel FREE to Connect to Our Research Experts@

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=256410424

Leading Market Players:

# Merck KGaA (Germany)

# General Electric Company (U.S.)

# Pall Corporation (U.S.)

# Parker Hannifin Corporation (U.S.)

# Sartorius Stedim Biotech Group (France) and many more…

The other important growth strategy adopted by players in this market is expansion, collaborations & partnerships. This strategy was adopted by the players market to enhance their product portfolio.

This report aims to provide insights into the global Transfection Reagents and Equipment Market. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Target Audience for this Report:

# Biopharmaceutical companies
# Biotechnology companies
# Transfection equipment, reagent, and kit manufacturing companies
# Suppliers and distributors of transfection reagents
# Research institutes
# Academic centers
# Venture capitalists

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139141146

Factors Influencing Global Growth:-

This growth can be attributed to factors such as advancements in transfection technology, global alliances among leading research institutes to trigger drug discovery, increase in R&D spending and research activities by pharmaceutical and biotechnology companies, increase in demand for synthetic genes, and rising incidence of cancer.

Moreover, development of large scale transfections, rising demand of protein therapeutics, and emerging markets across India and China are likely to create opportunities for players operating in the market.

Restraints:
# Selective Effectiveness of Transfection Reagents
# Home Brew Reagents Restrict Sale of Commercial Kits
# High Cost of Transfection Reagents

Opportunities:
# Large-Scale Transfections
# High-Growth Opportunities in Asian Market

Challenges:
# Transfection in Hard-To-Transfect Cells
# Cytotoxicity in Transfection – A Major Concern

Monetary Growth Expectations, Globally:

This report studies the global transfection reagents and equipment market from 2016 to 2021. This market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.

Geographical Growth Scenario:

On the basis of region, the global transfection reagents and equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

In 2016, North America is poised to account for the largest share of the market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering transfection reagents and equipment.

Read More:
https://www.marketsandmarkets.com/Market-Reports/transfection-reagents-equipment-market-139141146.html

Leading Market Players:

# Thermo Fisher Scientific Inc. (U.S.)
# Promega Corporation (U.S.)
# Hoffmann-La Roche Ltd. (Switzerland)
# QIAGEN N.V. (Netherlands) and many more…

Players operating in the transfection reagents and equipment market adopted strategies such as agreements, collaborations, and partnerships to strengthen their global presence.

This report aims to provide insights into the global intraoperative imaging market. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Target Audience for this Report:

# Intraoperative imaging equipment manufacturers and suppliers

# Neurosurgical/spinal surgery/orthopedic associations

# Neurosurgical/spinal surgery/orthopedic clinics and hospitals

# Academic institutes and universities

# Medical device manufacturers

# Research and consulting firms

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94836651

Factors Influencing Global Growth:-

A number of factors such as the growth in the aging population, rising burden of chronic diseases with changing lifestyles, increasing preference and demand for minimally invasive surgeries (MIS), and expanding applications of neurosurgery and orthopedic surgery are expected to fuel the growth of the market.

Restraints:

# High Cost of Intraoperative Imaging Systems

Opportunities:

# Emerging Markets

Challenges:

# Survival of New Entrants and Small Players

Monetary Growth Expectations, Globally:

The global Intraoperative Imaging market is projected to reach USD 2.06 Billion by 2021 from USD 1.61 Billion in 2016, at a CAGR of 5.2% during the forecast period of 2016 to 2021.

Geographical Growth Scenario:

Currently, North America dominates the intraoperative imaging market, followed by Europe. However, the Asia-Pacific market is expected to witness the highest growth during the forecast period.

The high growth in this market can be attributed to infrastructural improvements in healthcare facilities, growth in the geriatric population, increasing prevalence of orthopedic disorders, and growing disposable incomes in this region.

Read More:

https://www.marketsandmarkets.com/PressReleases/intraoperative-imaging.asp

Leading Market Players:

# GE Company (U.S.)

# Siemens AG (Germany)

# Koninklijke Philips N.V. (Netherlands)

# Ziehm Imaging GmbH (Germany)

# Toshiba Corporation (Japan)

# Medtronic (Ireland) and many more…

GE Healthcare, a subsidiary of General Electric Company (U.S.) is the leading player in the intraoperative imaging market. The company’s position is attributed to its strong brand image, robust product portfolio, and wide geographic presence. The company has a strong focus on innovation and quality. In 2015, the company filled ~3100 new patents in 10 research centers.

Siemens AG (Germany) has a robust geographic presence in more than 200 countries across the Americas, Asia, Australia, Europe, C.I.S., Africa, and the Middle East. To sustain its position in the intraoperative imaging market, the company focuses on adopting organic growth strategies. In line with this, the company received regulatory approvals and launched a number of products. For instance, in March 2016, Cios Fusion, Cios Connect, and Cios Select received FDA approval, and in April 2014, the company received FDA approval for Cios Alpha.

Philips Healthcare, a business segment of Koninklijke Philips NV (Netherlands) held the third position in the intraoperative imaging market. In 1955, a team of engineers from Philips Medical Systems developed the first mobile C-arm. The company has close to six decades of experience in the mobile C-arm segment.

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Objectives of the Study:

# To describe and forecast the surgical imaging market, in terms of value, by technology, application, and region

# To describe and forecast the surgical imaging market, by region–Asia Pacific (APAC), Europe, North America, and Rest of the World (RoW) along with their respective countries

# To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and challenges)

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

#To study the complete value chain of surgical imaging

# To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the surgical imaging ecosystem

# To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing competitive landscape for market leaders

# To analyze strategic approaches such as partnerships, agreements, alliances, collaborations, product launches, expansions, and acquisitions in the surgical imaging market

Target Audience for this Report:

# C-arms manufacturers and distributors

# Healthcare institutions

# Medical device vendors/service providers

# Research institutes

# Niche companies manufacturing imaging systems

# Research and consulting firms

# Venture capitalists

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210534462

Factors Influencing Global Industry Growth:-

The key factors driving the growth of this market are growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to advantages of FPDs over image intensifiers, reimbursement cuts on analog radiography systems, and increasing demand for minimally invasive procedures.

Restraints:

# High cost of instruments

Key Market Opportunities:

# Growing demand for data-integrated imaging systems

# Emerging markets to offer high growth opportunities

Challenges:

# Imaging obese patients

Major Market Developments:

# In 2017, Koninklijke Philips partnered with Government of Kenya and the United Nations to Establish the SDG (Sustainable Development Goals) Partnership Platform in Kenya to make primary healthcare more accessible

# In 2017, Koninklijke Philips established its first innovation center in Moscow, Russia

# In 2017, Siemens Received US FDA approval for its Cios Fusion, Cios Connect, and Cios Select

# In 2017, Ziehm Imaging Launched the new version of Ziehm Vision FD with a complementary metal oxide semiconductor (CMOS) flat-panel detector and a new CMOS flat-panel detector which allows for display of smaller pixels in the same quality

# In 2016, Shimadzu Corporation established an indirectly-owned subsidiary—Shimadzu Malaysia Sdn Bhd.

Industry’s Revenue Growth Expectations:

The surgical imaging market is expected to reach USD 1.63 Billion by 2022 from an estimated USD 1.25 Billion in 2017, at a CAGR of 5.5%

Geographical Growth Scenario:

North America is expected to account for the largest share of the surgical imaging market in 2017, followed by Europe, Asia Pacific (APAC), and the Rest of the World. The large share of this region can be attributed to a rising number of overuse sports injuries, and rising prevalence of CVD, along with the increasing number of cardiac arrest cases, and increase in the number of minimally invasive procedures performed in Canada.

However, Asia Pacific is expected to register the highest CAGR of 7.1% during the forecast period, owing to the rapid growth in geriatric population in Japan, healthcare reforms in China, improving healthcare infrastructure in India, and rising number of orthopedic and CVD procedures in Australia.

Read More:

https://www.marketsandmarkets.com/PressReleases/drug-discovery-services.asp

Leading Market Players:

# GE Healthcare (US)

# Koninklijke Philips (Netherlands)

# Siemens (Germany)

# Ziehm Imaging (Germany)

# Hologic (US)

# Shimadzu Corporation (Japan) and many more…

Agreements, collaborations, alliances, and partnerships were the key strategies adopted by players from 2014–2017. The players that adopted these strategies are Koninklijke Philips, Ziehm Imaging, GE Healthcare, Siemens, OrthoScan, Toshiba Medical Systems, and Medtronic.

Koninklijke Philips accounted for a share of 38% of the total number of agreements, collaborations, alliances, and partnerships in the surgical imaging market. This high share of the company can be attributed to its increasing number of partnerships and collaborations with hospitals which are the primary end users of C-arms.

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Objectives of the Study:

# To define, describe, segment, and forecast the global proteomics market by instrumentation technology, reagent, services and software, application, end user, and region.

# To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and industry-specific challenges)

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To forecast the size of the proteomics market in five main regions along with their respective key countries (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa)

# To profile key players in the global proteomics market and comprehensively analyze their core competencies and market shares

# To track and analyze competitive developments such as acquisitions; product launches; expansions; collaborations, partnerships, & agreements; and R&D activities of the leading players in the proteomics market

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731

Recent Developments:

# In 2018, Thermo Fisher Scientific, Inc. and Symphogen formed a collaboration under which Symphogen will use the Thermo Scientific Q Exactive Plus Orbitrap LC/MS/MS system with its BioPharma Option to create, test, and validate platform workflows for intact and native mass analysis of therapeutic monoclonal antibody (mAb) mixtures.

# In 2018, Thermo Fisher Scientific, Inc. launched TSQ Fortis Triple Quadrupole Mass Spectrometer and UHPLC-MS Ultrapure Solvents.

# In 2018, Agilent Technologies acquired Advanced Analytical Technologies, Inc. to enhance its technology base and provide a comprehensive set of solutions for NGS workflows.

# In 2017, Merck KGaA signed an MoU with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development. Under the agreement, Merck would supply Mobius single-use systems, cell line, cell culture media, and chromatography to accelerate the development of biologic drugs.

Critical questions answered in the report:

# How will the current technological trends affect the proteomics market in the long term?

# How is the service market for proteomics moving?

# What are the application areas of the market?

# Which regions are likely to grow at the highest CAGR?

# What are the growth strategies being implemented by major market players?

Factors Influencing Global Industry Growth:-

Growth in this market is driven by increasing research activity in the area of personalized medicine and drug discovery, increasing R&D expenditure by the pharmaceutical and biotechnology sector, and rising government funding for proteomics.

Restraints:

# High Cost of Instruments

Key Market Opportunities:

# Growing Prominence of Nanoproteomics - the Convergence of Nanotechnology and Proteomics

# Personalized Proteomics for Precision Health

# High Growth Opportunities in Emerging Countries

Challenges:

# Data Management in Proteomics Research

# Low Biomarker Discovery-To-Approval Ratio

Industry’s Revenue Growth Expectations:

The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%.

Geographical Growth Scenario:

In 2018, North America dominated the global proteomics market, followed by Europe. Increasing investments in the development of structure-based drug designs, growing academic and government investments in genomics and proteomics research, rising demand for high-quality research tools for data reproducibility, and rising focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the factors propelling the growth of the market in the region.

Read More: https://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html

Leading Market Players:

# Thermo Fisher Scientific, Inc. (US)

# Agilent Technologies, Inc. (US)

# GE Healthcare (US)

# Bio-Rad Laboratories, Inc. (US)

# Danaher Corporation (US)

# Luminex Corporation (US) and many more…

This study involved four major activities in estimating the current size of the Healthcare Cloud Computing Market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Recent Developments:

# To define, describe, and forecast the global market by application, deployment model, pricing model, service model, component, end user, and region

# To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders

# To forecast size of market segments in North America, Europe, Asia Pacific, and RoW

# To strategically profile key players in the global market and comprehensively analyze their core competencies

# To track and analyze competitive developments such as mergers and acquisitions; product developments; agreements, partnerships and collaborations; and research and development activities in the market

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=347

Targeted Audience in This Study:

# Healthcare IT Providers

# Healthcare insurance companies/payers

# Healthcare institutions/providers (hospitals, medical groups, physician practices, diagnostic centers, and outpatient clinics)

# Research and development companies

# Government bodies and municipal corporations

# Business research and consulting service providers

# Venture capitalists

Factors Influencing Global Industry Growth:-

The key factors driving the growth of this market include increasing adoption of big data, wearable devices, and IoT in healthcare; advantages of cloud usage (such as improved storage, flexibility, and scalability of data); implementation of healthcare reforms such as the Patient Protection and Affordable Care Act; and the dynamic nature of health benefit plan design.

Restraints:

# Concerns Over Data Security and Privacy

# Migration from Legacy Systems is considered as A Tedious Task by Providers

Challenges:

# Issues Related to the Interoperability of Cloud

Key Market Opportunities:

# Emergence of Telecloud

# Formation of Accountable Care Organizations

Industry’s Revenue Growth Expectations:

The global healthcare cloud computing market is expected to reach USD 44.93 billion by 2023 from USD 19.46 billion in 2018, at a CAGR of 18.2%.

Geographical Growth Scenario:

In 2018, North America held the largest share of the healthcare cloud computing market, followed by Europe. Factors such as the increasing adoption of EHRs among medical professionals and active participation by private sector players in the development of the healthcare industry in that region are contributing to the dominant share of this region.

Read More:
https://www.marketsandmarkets.com/Market-Reports/cloud-computing-healthcare-market-347.html

Leading Market Players:

# CareCloud Corporation (US)

# ClearData Networks Inc. (US)

# Athenahealth (US)

# Cerner Corporation (US)

# Epic Systems Corporation (US)

# NextGen Healthcare (US) and many more…

Agreements, partnerships, collaborations, alliances, expansions, acquisitions, and product launches were the major strategies adopted by key players to achieve growth in this market. Agreements, partnerships, collaborations, and alliances accounted for 45.3% of the total strategies adopted by the players in this market.

Product launches accounted for 21.7% of the total strategies adopted by the players in the healthcare cloud computing market from 2015–2018. Players adopted this strategy to strengthen their existing product portfolios, increase their global presence, and enhance customer experience.

This study involved four major activities in estimating the current size of the healthcare IT market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the sizes of segments and subsegments.

Recent Developments:

# In 2019, Philips launched Cares Aging & Caregiving service.

# In 2018, Change Healthcare launched Dx Gap Advisor

# In 2017, Optum acquired DaVita Medical Group (US). The acquisition of DaVita enhanced Optum’s physician-led primary, specialty, in-home, and surgery-care delivery services business.

# In 2017, Cognizant acquired TMG Health (US) to expand its business process-as-a-service solutions for government and public health programs

# In 2018, Optum collaborated with Humana (US), MultiPlan (US) and Quest Diagnostics (US) to form a group to explore the blockchain technology to improve data quality and reduce administrative costs in healthcare

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252

Key Questions Addressed in the Report:

# Who are the top 10 players operating in the healthcare IT market?

# What are the driving factors, restraints, opportunities, and challenges in the market?

# What are the industry trends as well as the current scenario in the healthcare IT market?

# What are the growth trends in the market at the segmental and overall market levels?

Factors Influencing Global Industry Growth:-

The demand for healthcare IT solutions and services is driven by government mandates & support for healthcare IT solutions, rising use of big data in healthcare, high returns on investment for healthcare IT solutions, and the need to curtail escalating healthcare costs. However, IT infrastructural constraints in developing countries are expected to restrain the growth of this market during the forecast period.

Restraints:

# IT Infrastructural Constraints in Developing Countries

Challenges:

# Security Concerns

# Interoperability Issues

Key Market Opportunities:

# Rising Use of Healthcare IT Solutions in Outpatient Care Facilities

# Growing Mhealth, Telehealth, and Remote Patient Monitoring Markets

# Cloud-Based EHR Solutions

# Shift towards Patient-Centric Healthcare Delivery

Industry’s Revenue Growth Expectations:

The healthcare IT market is projected to reach USD 390.7 billion by 2024 from USD 187.6 billion in 2019, at a CAGR of 15.8% during the forecast period.

Geographical Growth Scenario:

The Healthcare IT market is broadly segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Healthcare IT market in 2018. The large share of this region can be attributed to the technological competencies of healthcare industry and presence of well-established healthcare IT infrastructure in this regions.

Changing regulatory requirements for improving quality of healthcare and increasing patient safety and rising healthcare expenditures are some of the key factors driving the growth of the healthcare IT market in North America.

Read More:

https://www.marketsandmarkets.com/Market-Reports/healthcare-it-252.html

Leading Market Players:

# Optum (US)

# Cerner (US)

# Cognizant (US)

# Change Healthcare (US)

# Philips Healthcare (Netherlands)

# Epic Systems (US) and many more…

Objectives of the Study:

# To define, describe, and forecast the vascular access devices market by type, application, end user, and region

# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

# To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders

# To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)

# To profile the key players and analyze their market shares and core competencies

# To track and analyze competitive developments such as product launches, approval, agreements, collaborations, and acquisitions in the global vascular access device market

Targeted Audience of This Study:

# Vascular access device manufacturers and distributors

# Interventional cardiology vascular device manufacturers

# Research and consulting firms

# Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)

# Research institutes

# Vendors/service providers

# Niche companies manufacturing novel vascular access devices

# Research and consulting firms

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122149686

Factors Influencing Global Industry Growth:-

The major drivers for the market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients.

Restraints:

# High Costs Involved in the Placement and Maintenance of Vascular Access Devices

# Product Recalls and Failures

Challenges:

# Shortage of Skilled Professionals

# Risks Associated With Vascular Access Devices

Opportunity:

# Technological Advancements

Industry’s Revenue Growth Expectations:

The global vascular access devices market is expected to reach USD 5.45 Billion by 2022 from USD 3.87 Billion in 2017, at a CAGR of 7.1%.

Geographical Growth Scenario:

North American segment is expected to account the largest share of the market in 2017. Market growth in this region is primarily driven by factors such as the high prevalence of cardiovascular diseases; increasing number of research studies and clinical trials for vascular access devices in the U.S.; and the increase in chemotherapy procedures.

Moreover, the increasing number of cardiac arrest cases, an increase in the number of minimally invasive procedures and the increase in cancer incidences in Canada are other factors driving the growth of this market in this region.

Read More: 

https://www.marketsandmarkets.com/Market-Reports/vascular-access-device-market-122149686.html

Leading Market Players:

# Becton Dickinson and Company (U.S)

# C.R.Bard, Inc. (U.S.)

# Smiths Medical, Inc. (U.K.)

# Teleflex Incorporated (U.S.)

# B Braun Melsungen Ag (Germany)

# AngioDynamics (U.S.) and many more…

The study involved two major activities in estimating the Current and Expected Market Size of the Global Human Microbiome Market in the future. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Recent Developments:

# In 2019, Seres collaborated with AstraZeneca to get a better understanding of the microbiome in augmenting the efficacy of cancer immunotherapy, including potential synergy with AstraZeneca compounds.

# In 2018, Enterome entered into a co-development and co-promotion agreement with Takeda for its investigational drug candidate EB8018. This drug is used in patients with Crohn's disease and has the potential to expand its use to other gastrointestinal (GI) disorders and liver diseases.

# In 2016, 4D Pharma acquired the production assets of Instituto Biomar to expand its clinical and production capabilities of live biotherapeutics.

Key questions addressed by the report:

# Who are the major market players in the human microbiome market?

# What are the regional growth trends and the largest revenue-generating regions for the market?

# What are the major drivers and challenges in the market?

# What are the major product segments in the market?

# What are the major technologies used in the human microbiome research spending market?

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37621904

Factors Influencing Global Industry Growth:-

Microbiomes are responsible for a wide variety of metabolic and developmental processes—from food digestion to vitamin synthesis and even brain function. They also play a major role in human conditions, such as obesity and inflammatory bowel disease.

Market growth is largely driven by the increasing focus on the development of human microbiome therapy. It has also become a validated target for drug development. The growing number of collaborations between market players is expected to offer a wide range of growth opportunities for market players during the forecast period.

Restraints:

# Lack of Expertise and Detailed Research

# Barriers in Proving the Causal Link Between Dysbiosis and Disease

Challenges:

# Government Regulations

Industry’s Revenue Growth Expectations:

The global human microbiome industry is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5 % during the forecast period.

Geographical Growth Scenario:

Europe to account for the largest share of the human microbiome market in 2022

Geographically, the global human microbiome market is segmented into four major geographies— North America, Europe, the Asia Pacific, and the Rest of the World (RoW). Europe is expected to account for the largest share of the global human microbiome market in 2022. The large share of this regional segment is mainly due to the high research activity in this region.

Read More:

https://www.marketsandmarkets.com/Market-Reports/human-microbiome-market-37621904.html

Leading Market Players:

# Enterome Bioscience (France)

# E.I. du Pont de Nemours and Company (DuPont) (US)

# 4D Pharma (UK)

# Seres Therapeutics (US) and many more…

Various growth strategies have been adopted by these players, such as product launches, agreements, and acquisitions to increase their presence in the global human microbiome market.

The global Nerve Monitoring Systems Market has been segmented on the basis of product, technology, application, end user, and region. Based on product, the nerve stimulation electrodes and probes segment commanded the largest share of the global nerve monitoring system market in 2017.

Key Questions Addressed in this Report:

# What are the business growth strategies adopted by key market players to maintain their market position across key geographies?

# What is the existing developmental pipeline of major nerve monitoring systems among Medtech manufacturers as well as academia?

# Growing number of trauma based surgical procedures is a key trend in clinical management. What impact trauma based surgical procedures will have on nerve monitoring systems market during the forecast period?

# What alternative technologies/therapies are currently being used for nerve monitoring worldwide? What competition they pose for key nerve monitoring systems market players.

Factors Influencing Global Industry Growth:-

Factors such as increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are expected to drive the demand for nerve monitoring products during the study period.

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155669000

Restraints:

# Limited Awareness about Nerve Monitoring Among Healthcare Professionals

Market Opportunities:

# Increased Clinical Studies in the Field of Nerve Monitoring

# Emerging Markets

Industry’s Revenue Growth Expectations:

The Global Nerve Monitoring System Market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period.

Geographical Growth Scenario:

North America accounted for the largest share of the nerve monitoring system market

Geographically, the nerve monitoring system market is segmented into North America, Europe, Asia, and the Rest of the World. North America is estimated to account for the largest share of the market in 2017, which is driven by the presence of a large patient population accompanied by a well-established medical reimbursement policy.

Target Audience:

# Nerve monitoring product manufacturers

# Nerve monitoring product suppliers and distributors

# Contract manufacturers

# Healthcare service providers [including hospitals, surgical centers, and ambulatory surgical centers (ASCs)]

# Research laboratories and academic institutes

# Clinical research organizations (CROs)

# Government regulatory authorities

# Independent associations and non-government organizations

# National and international regulatory authorities

# Market research firms

Read More: https://www.marketsandmarkets.com/PressReleases/nerve-monitoring-system.asp

Leading Market Players:

# Medtronic (Ireland)

# NuVasive (US)

# Nihon Kohden (Japan)

# Bovie Medical (US)

# Natus Medical (US)

# Checkpoint Surgical (US) and many more…

Analysis of the market developments between 2015 and 2017 revealed that several growth strategies such as product launches, acquisitions, mergers, and expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the nerve monitoring system market. Among these business strategies, mergers and acquisitions, were the most widely adopted growth strategies by players to strengthen their product portfolios and to remain competitive in the market.

The antibody production market comprises products that are required during the different stages of bioprocessing of antibodies, such as upstream processing, downstream processing, and filtration.

Objectives of the Study:

# To define, describe, and forecast the Global Antibody Production Industry on the basis of process, end user, and region

# To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)

# To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market

# To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

# To forecast the size of the market with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World

# To strategically profile the key players in the global antibody production market and comprehensively analyze their core competencies

# To track and analyze competitive developments such as joint ventures and alliances, mergers and acquisitions, new product/technology development, and research and development activities of the leading players in the global market

Factors Influencing Global Industry Growth:-

A number of factors such as the improved approval rate for therapeutic antibodies by regulatory authorities, patent expiry of blockbuster monoclonal antibodies, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies are key drivers for the growth of the antibody production market. Moreover, the increasing risk of infectious diseases and rising demand for protein therapeutics are expected to drive market growth during the forecast period.

Looking Out for More Details | Don’t Hesitate to Download the PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=181543091

Restraints:

# Cost Constraints Related to the Adoption of Membrane Filters

Opportunities:

# Rising Demand for Protein Therapeutics

# Increasing Risk of Infectious Diseases

# Patent Expiry of Blockbuster Mabs

Industry’s Revenue Growth Expectations:

The global market is projected to reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, at a CAGR of 12.3% during the forecast period of 2016 to 2021.

Geographical Growth Scenario:

Geographically, the global antibody production market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, Middle East, and Africa). North America is expected to account for the largest share of the antibody production market in 2016, followed by Europe. The Asia-Pacific region offers significant growth opportunities for companies offering antibody production products, and is projected to grow at the highest CAGR during the forecast period.

Target Audience:

# Equipment and consumable manufacturing companies

# Equipment and consumable suppliers and distributors

# Research institutes

# Venture capitalists

# Biotechnology and pharmaceutical companies

# Diagnostic laboratories

Read More:

https://www.marketsandmarkets.com/PressReleases/antibody-production.asp

Leading Market Players:

# GE Healthcare (U.S.)

# Thermo Fisher Scientific, Inc. (U.S.)

# Sartorius AG (Germany)

# Merck KGaA (Germany)

# Pall Corporation (U.S.) and many more…

New product launches; expansions; agreements, alliances, collaborations, and partnerships; mergers and acquisitions; and others (new service launches, product enhancements, and spin-offs) are the major strategies followed by players to achieve growth in this market. New product launches accounted for ~51% of the total developments undertaken by the players in this market. The key players that adopted this strategy are Eppendorf AG (Germany), Sartorius AG (Germany), Merck KGaA (Germany), GE Healthcare (U.S.), and Agilent Technologies, Inc. (U.S.).